CRON, CA22717L1013

Cronos Group stock falls 3.69 percent as target rises

Published on 09/30/2026 at 19:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cronos Group stock faces a C$7.00 target after TD Securities lifted it from C$6.00 on September 28, 2026. Q2 revenue reached USD 53.01 million.

CRON, CA22717L1013, Illustration mit AI erstellt.
CRON, CA22717L1013, Illustration mit AI erstellt.

Cronos Group (ISIN CA22717L1013) was trading at EUR 2.87 at Lang & Schwarz on September 30, 2026 at 7:32 p.m. CEST, down 3.69 percent versus the prior close of EUR 2.98. The latest analyst move keeps the cannabis company in view after Markets Insider reported on September 28, 2026 that TD Securities raised its target from C$6.00 to C$7.00 and kept a Buy rating.

Target rises after investor day

The target increase followed Cronos' September 24, 2026 Investor Day, which presented the GrowCo facility, cannabis genetics platform and branded product strategy. MarketScreener reported that Cronos hosted the event at its Kingsville, Ontario facility and identified Cronos as listed on NASDAQ and the TSX.

The analyst case centers on production capacity and branded cannabis demand in Canada, Israel and international markets. That operational argument now sits against the September 30, 2026 Lang & Schwarz quote, which is 58.71 percent below the C$7.00 target only when currencies are ignored, so the two values should not be combined into one return calculation.

Q2 revenue beats consensus

Cronos delivered USD 53.01 million in Q2 2026 revenue against a USD 44.20 million consensus estimate, while adjusted earnings per share reached USD 0.09 versus USD 0.01 expected, according to MarketBeat in its September 12, 2026 report. The comparison gives the recent target increase a concrete operating base rather than relying only on cash holdings or sector sentiment.

In Q2 2026, gross profit was USD 28.45 million, equal to a 53.67 percent gross margin, and net income was USD 35.66 million. Cash from operating activities reached USD 24.01 million in the quarter, while total cash and cash equivalents stood at USD 797.02 million on June 30, 2026.

Stock trades below yearly high

The finance snapshot places Cronos Group's market capitalization at USD 1.2 billion on September 30, 2026. Its 52-week range was USD 2.28 to USD 3.61, leaving the Lang & Schwarz euro quote as a separate German-market reference rather than a direct comparison with the NASDAQ figures.

Cronos Group was trading at EUR 2.87 at Lang & Schwarz on September 30, 2026 at 7:32 p.m. CEST, down 3.69 percent versus the Lang & Schwarz prior close of EUR 2.98 on September 29, 2026.

Cronos Group market snapshot

  • Company: Cronos Group Inc.
  • ISIN: CA22717L1013
  • Ticker: CRON
  • Price Lang & Schwarz (as of September 30, 2026, 7:32 p.m. CEST): EUR 2.87
  • Change versus prior close: minus 3.69 percent
  • Prior close Lang & Schwarz (September 29, 2026): EUR 2.98
  • Market capitalization: USD 1.2 billion (as of September 30, 2026)
  • 52-week range: USD 2.28-USD 3.61 (as of September 30, 2026)
  • Sector / Industry: Healthcare / Drug Manufacturers - Specialty & Generic

More news and analyses on Cronos Group stock

Disclaimer...

en | CA22717L1013 | CRON | boerse | 70205811 | bgmi